Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-017452
Filing Date
2021-07-23
Accepted
2021-07-23 16:22:27
Documents
1
Period of Report
2021-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4864
  Complete submission text file 0001437749-21-017452.txt   6144
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Issuer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3057 PERKINS LANE W SEATTLE WA 98199
Business Address
Miller Langdon L (Reporting) CIK: 0001641593 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32954 | Film No.: 211111094